CRISPR Co-Founder Jennifer Doudna on Future of Biotech
Sixth Street Chief Science Adviser and Nobel laureate Jennifer Doudna, co-founder of the CRISPR genome editing technology 10 years ago, and Sixth Street Vice Chairman and Partner R. Martin Chavez join Emily Chang to discuss the future of CRISPR and its potential for commercialization.
Видео CRISPR Co-Founder Jennifer Doudna on Future of Biotech канала Bloomberg Technology
Видео CRISPR Co-Founder Jennifer Doudna on Future of Biotech канала Bloomberg Technology
Показать
Комментарии отсутствуют
Информация о видео
Другие видео канала
Bloomberg Technology 10/18/2023AI-Related Jobs Demand Rising in NYCThe Fintech Ecosystem in NYCWestly: Tesla Will Be in Driver's Seat for a Long TimeNetflix's Two Big Bets: New Ad-Tier and Password-SharingFTX Trial, Nvidia Chips War | Bloomberg Technology 10/17/2023The Coterie Wants to Improve Tools for Retail InvestorsNew York City Releases Its Plan to Embrace AIFTX Trial Impact on Blockchain IndustryThis is Nvidia’s H100 GPU #technology #shortsBloomberg Technology 10/16/2023New York's Tech EcosystemSocial Media's Role in the Israel-Hamas WarExclusive look inside Nvidia's AI supercomputerIPhone 15 Sales Start Off Slow in China#ai weekly— TMSC earnings, Meta’s chatbots #technology #shortsMicrosoft Deal, Intelligence in Israel | Bloomberg Technology 10/13/2023The Importance of Intelligence in Israel-Hamas WarRUIN Trailer: Money, Ego and Deception at FTXLive From Screentime | Bloomberg Technology 10/12/2023Making and Testing Rocket Engines Isn't Easy